Additionally, antigens released after lysis of infected cells can be captured by bystander DCs and presented to MHC-class I molecules to CD8+ T cells, which is termed antigen cross-presentation and plays a vital in generating an effective cancer vaccine [90, 91]. Here, CD8A is linked to cancer.